Arantxa Tabernero

9PUBLICATIONS
44CO-AUTHORS
MechanobiologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Cx43 levels guide apicobasal polarity in regenerating airway epithelial cells.

|Feb 27, 2026
The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis.

Pilar Cerveró-García, Enrique Jiménez-Madrona, Andrea Álvarez-Vázquez

|Apr 28, 2025
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma.

Laura García-Vicente, María Martínez-Fernández, Michael Borja

|Mar 20, 2024
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.

Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García

|Oct 10, 2022
Src: coordinating metabolism in cancer.

Sara G Pelaz, Arantxa Tabernero

|Sep 10, 2021
Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43266-283 in Glioblastoma Stem Cells.

Sara G Pelaz, Claudia Ollauri-Ibáñez, Concepción Lillo

Pageof 2

Frequent Collaborators

3 joint publications

Claudia Ollauri-Ibáñez

3 joint publications

Andrea Álvarez-Vázquez

3 joint publications

Raquel Flores-Hernández

2 joint publications

Sara G Pelaz